GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Ovid Technologies (Wolters Kluwer Health)  (3)
  • 1
    In: Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 125, No. suppl_10 ( 2012-03-13)
    Abstract: Introduction and objectives. Measures of adiposity such as waist circumference (WC) and waist-to-hip ratio (WHR) are associated with adverse cardiovascular events and diabetes independent of body mass index (BMI). WC and WHR have high heritability and multiple susceptibility loci have been identified across the genome, including GRB14 , LYPAL1 , and VEGFA . We aim to identify novel loci associated with WC and WHR using a bespoke SNP array focused on cardio-centric candidate genes. Methods. We assessed the association between SNPs and anthropometry phenotypes WC adjusted for BMI (cm), and WHR adjusted for BMI among 51990 individuals of European ancestry from NHLBI’s Candidate Gene Association Resource (CARe) project and 14 other cohorts. The study population consisted of women and men aged 20 to 80, of which 65% were females. Individuals were genotyped using the ITMAT/Broad/CARE (IBC) chip, which includes ∼50,000 densely mapped cosmopolitan tagged SNPs across ∼2100 candidate genes. We modeled each trait as a function of age, study site, and ancestry, and conducted a fixed-effects meta-analysis. Results. Three novel loci reached our Bonferroni adjusted threshold for statistical significance (P 〈 2E-6). The A allele of SNP rs761422 in gene MFAP2 was associated with decreased WC adjusted for BMI (P=4.4E-7), and has previously been reported in a height GWAS. The C allele of SNP rs2811337 near TMCC1 , involved in signaling pathways, and the A allele of SNP rs7302703 in gene HOXC10 , involved in cell differentiation, were associated with decreased WHR adjusted for BMI (P=8.6E-9 and P=2.8E-7, respectively). Fourteen loci have been previously reported in association with WHR adjusted for BMI, five of which, were included on the IBC chip. Of the five, three also reached statistical significance with the same direction of effect in our sample: RSPO3 (P=3.0E-10), ADAMTS9 (P=8.6E-9),and ITPR2 (P=5.6E-8). All SNPs were common variants (MAF 〉 10%). Fine mapping is currently underway to determine whether each locus may contain multiple independent signals. Replication cohorts have been identified and we are working to verify the novel loci and investigate sub-significant loci. Conclusions . In 51990 European decent individuals typed on a dense IBC chip, we identified 3 novel loci and replicated 3 additional loci. Significant loci among WC adjusted for BMI, and WHR adjusted for BMI were distinct from one another, indicating each measure of adiposity may be capturing distinct underlying phenotypes and thus different pathways through which risk alleles affect adiposity. We will pursue further assessment of risk loci and adiposity through fine mapping and follow-up genotyping.
    Type of Medium: Online Resource
    ISSN: 0009-7322 , 1524-4539
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2012
    detail.hit.zdb_id: 1466401-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Epidemiology, Ovid Technologies (Wolters Kluwer Health), Vol. 30, No. 5 ( 2019-09), p. 687-694
    Abstract: Brominated flame retardants, including polybrominated biphenyls (PBB), are persistent compounds reported to affect sex hormones in animals; less is known about potential effects in humans. An industrial accident in 1973–1974 exposed Michigan residents to PBB through contaminated food. We examined whether this exposure to PBB had long-term effects on menstrual cycle function. Methods: In 2004–2006, we recruited reproductive-aged women in the Michigan PBB Registry who were not pregnant, lactating, or taking hormonal medications. Participants kept daily diaries and provided daily urine samples for up to 6 months. We assayed the urine samples for estrone 3-glucuronide (E 1 3G), pregnanediol 3-glucuronide (Pd3G), and follicle stimulating hormone (FSH). We fit linear mixed models among women aged 35–42 years to describe the relation between serum PBB levels and log-transformed, creatinine-adjusted daily endocrine levels among women who were premenarchal during the exposure incident in 1973–1974 (n = 70). Results: We observed that high ( 〉 3.0 parts per billion [ppb]) and medium ( 〉 1.0–3.0 ppb) PBB exposure were associated with lower E 1 3G levels across the menstrual cycle and lower FSH levels during the follicular phase, compared with low PBB exposure (≤1.0 ppb). High PBB exposure was also associated with lower Pd3G levels across the cycle compared with low PBB exposure, whereas Pd3G levels were similar in women with medium and low PBB exposure. Conclusion: Our results are consistent with a hypothesized effect of exposure to an exogenous estrogen agonist but the modest sample size of the study requires cautious interpretation.
    Type of Medium: Online Resource
    ISSN: 1044-3983
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2019
    detail.hit.zdb_id: 2042095-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Circulation: Heart Failure, Ovid Technologies (Wolters Kluwer Health), Vol. 8, No. 1 ( 2015-01), p. 49-56
    Abstract: Vitamin D supplementation may be an inexpensive intervention to reduce heart failure (HF) incidence. However, there are insufficient data to support this hypothesis. This study evaluates whether vitamin D plus calcium (CaD) supplementation is associated with lower rates of HF in postmenopausal women and whether the effects differ between those at high versus low risk for HF. Methods and Results— Analyses were restricted to 35 983 (of original 36 282) women aged 50 to 79 years old in the Women’s Health Initiative randomized trial of CaD supplementation who were randomized 1:1 in a double-blinded fashion to receive 1000 mg/d of calcium plus 400 IU/d of vitamin D 3 or placebo. Overall, 744 adjudicated incident HF cases (intervention, 363; control, 381) occurred during a median follow-up of 7.1 (interquartile range, 1.6) years. CaD supplementation, compared with placebo, was not associated with reduced HF risk in the overall population, hazard ratio, 0.95; P =0.46. However, CaD supplementation had differential effects ( P interaction=0.005) in subgroups stratified by baseline risk status of HF defined by the presence (high risk=17 449) or absence (low risk=18 534) of pre-existing HF precursors including coronary heart diseases, diabetes mellitus, or hypertension: 37% (hazard ratio, 0.63 [95% confidence interval, 0.46–0.87]) lower risk of HF in the low-risk versus hazard ratio, 1.06; P =0.51, in the high-risk subgroups. Conclusions— CaD supplementation did not significantly reduce HF incidence in the overall cohort, however, it was beneficial among postmenopausal women without major HF precursors while of little value in high-risk subgroups. Additional studies are warranted to confirm these findings and investigate the underlying mechanism. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT00000611.
    Type of Medium: Online Resource
    ISSN: 1941-3289 , 1941-3297
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2015
    detail.hit.zdb_id: 2428100-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...